Analyze in Oracle Skeptic
S5/10Economic
Pharma stocks slide as Trump's 100% generic drug tariff plan spooks investors
Indian drug shares declined Wednesday following US President Trump's tariff announcement. These proposed tariffs will significantly impact companies with substantial US revenue exposure.
Analysts suggest investors should now focus on domestically oriented Indian pharmaceutical firms. The Nifty Pharma index saw a notable decrease, while the benchmark Nifty 50 also fell.
Negotiations are expected given India's vital role in supplying affordable medicines to the US.
Source: Economic TimesOriginal source
Click a tag to subscribe via email/Telegram (manage channels in Account).
⚠️ A model estimate of cascade risk — not a guarantee and not buy/sell. Calibration uses resolved outcomes only; monitor confirmation indicators below.
A
Эскалация
Forecast derived from cascade analysis. Watch confirmation indicators below.
Horizon: 7–30 days
Exact probability, cascade chain, and confirmation indicators unlock for approved members.